Eric Lefkofsky Explains How Technology Helps Pancreatic Cancer Research Outcomes
Pancreatic cancer is a growing problem in the United States. Over 50,000 people are diagnosed with it this year alone. Eric Lefkofksy, co-founder of TempusLabs explains the importance of stepping back and looking at what needs to be done to help prevent and fight pancreatic cancer.
Research and funding has grown considerably from independent agencies as well as sponsoring foundations with regards to pancreatic cancer. They’ve supported the development and expansion of new technologies when it comes to genome sequencing significantly. Not only is it possible for patients to receive new and improved treatment options, but data collection methods have also improved when it comes to getting genetic mutations and abnormalities documented.
Immunotherapies and targeted methods of therapeutic treatment can transform the way that pancreatic cancer is treated, especially when compared to other forms of cancer. Advances in the way that genome therapy is executed and practiced will definitely help pancreatic cancer patients in surviving and healing faster. Information and awareness about pancreatic cancer has grown considerably in recent times. Over 6,000 scientific citations were registered in the National Library of Medicine catalog last year. This was more than twice what was submitted less than a decade ago in 2005. Clinical trials are important and have also been growing when it comes to pancreatic cancer treatment. Many unique therapies and novel systems are trying to address the molecular state of tumors and Immunology in order to better serve pancreatic cancer patients.
Eric Lefkofksy is interested in furthering the way that technology and research can work together in helping cancer patients survive. Molecular research and genetic analysis are some of the ways that research can build on what we have learned through sequencing. Developing drugs that are based on immunological research can improve the way that diagnosis and treatment takes place.
Refining an understanding of pancreatic cancer is also important through future clinical trials and research objectives. Patient information especially about molecular profiles can be essential in developing treatment and evolving technology alongside data science. Eric Lefkofsky explains the importance of continued research and investigation of pancreatic cancer, as the technology that currently exists has the potential to improve treatment outcomes. Continued efforts from pancreatic research organizations and clinical hospital settings, will make it possible for new treatment methods to address pancreatic cancer.
His Facebook Page: https://www.facebook.com/eplefkofsky/